What we've found so far is that hypertension treatment and control rates differ significantly between high-income and lower-income regions. The evidence we've reviewed leans toward higher success in treating and managing high blood pressure in countries like South Korea, Canada, and Iceland, where most people with high blood pressure receive treatment and achieve control [1]. In contrast, in many parts of Africa, South Asia, and the Pacific, fewer than 1 in 4 people with hypertension get treatment, and even fewer have their blood pressure under control [1].
Our analysis of the available research shows a clear gap in how well high blood pressure is managed depending on where people live. In some high-income or well-resourced countries, health systems appear to identify, treat, and support people with hypertension effectively. But in lower-income regions, access to diagnosis, medication, and ongoing care may be limited, leading to much lower treatment and control rates [1].
We don’t have enough data to say exactly why these differences exist, but the pattern we see suggests that healthcare infrastructure, access to medicine, and public health efforts may play important roles. What we can say is that the evidence we’ve reviewed so far points to a global imbalance in hypertension care.
This doesn’t mean every high-income country performs well or that progress isn’t possible in lower-income settings — our current analysis just highlights a general trend based on the data available. As more studies are done, especially in underrepresented regions, our understanding may improve.
Practical takeaway: If you live in a place with strong healthcare access, you may be more likely to get help for high blood pressure — but if you're in a region with fewer resources, getting diagnosed and staying on treatment could be much harder. Where you live should not decide your health outcome, but right now, it often does.
2 items of evidenceView full answer